Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, with reference to the contract awarded by her Department to Ethypharm UK Ltd on 27 January 2022 for the storage and management of the Department's Naloxone buffer stock, how many packs of Naloxone were distributed from the buffer stock for use by patients in the UK in the (a) 2021-22, (b) 2022-23, and (c) 2023-24 financial year.

No packs of naloxone were distributed from the buffer stock for use by patients, in the financial years 2021/22, 2022/23, or 2023/24. The buffer stock is maintained in case of an unprecedented demand for naloxone arising, that would exceed the capacity of business-as-usual stock, for instance due to an incident of unusually harmful opioids. Such an incident has not arisen to date. The Government remains committed to maintaining this vital precautionary measure, and would authorise the release of buffer stock supplies when needed.